Home | Abiomed.com
Abiomed provides on-site, on-call and online clinical support to help health care professionals achieve the best possible outcome for the patient.
Media Kit | Abiomed.com
Life at Abiomed; Diversity & Inclusion; Students; Investors; Icon used to search. Icon used to close search modal. Media Kit Resources for Journalists and News Media Filter Filter Results Product . Impella 5.5 with SmartAssist ® (1) Impella CP with ...
Our Story | Abiomed.com
Abiomed was founded in 1981 for the purpose of developing the world's first artificial heart. This interactive timeline shows how Abiomed’s mission evolved to focus on native heart recovery. Through its history, Abiomed has been dedicated to bringing the most advanced and innovative technology to patients and physicians.
Abiomed® - Leading in Heart and Lung Recovery
Abiomed is a leading provider of groundbreaking medical technology that provides circulatory and oxygenation support. The Impella® heart pump platform is designed to enable the heart to rest and recover by improving blood flow and/or temporarily assisting with …
Imprint | Footer | Abiomed.eu
Here you will find the imprint and all important information about Abiomed. About Abiomed: Abiomed is an innovative global leader in medical technology and makes a significant contribution to cardiac support and restoration of cardiac function with its unique product portfolio.
About Us - Abiomed
Abiomed is a leading provider of groundbreaking medical technology that provides circulatory and oxygenation support. The Impella® heart pump platform is designed to enable the heart to rest and recover by improving blood flow and/or temporarily assisting with …
Home | Abiomed
Recovering Hearts. Saving Lives. Abiomed is a leading provider of groundbreaking medical technology that provides circulatory support.
Johnson & Johnson Completes Acquisition of Abiomed
2022年12月22日 · Johnson & Johnson (NYSE: JNJ), the world’s largest, most diversified healthcare products company, today announced it has completed its acquisition of Abiomed, Inc. Abiomed is now part of Johnson & Johnson and will operate as a standalone business within Johnson & Johnson’s MedTech segment.
Impella RP Post-Approval Study Data Presented at ACC 2019
2019年3月18日 · Abiomed, a leading provider of breakthrough heart support technologies and the maker of the Impella RP heart pump, announces that survival data from the 18 month post-approval study of 42 Impella RP patients was presented at the American College of Cardiology’s (ACC) 68th Annual Scientific Session.
Explore Abiomed® Products and Clinical Services
Abiomed provides collaborative patient management with on-site, on-call and online clinical support to ensure quality and help health care professionals achieve the best possible outcome for the patient.